M1 Polarized Microglia
Introduction
<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">M1 Polarized Microglia</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000129](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000129)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000129](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000129)</td>
</tr>
<tr>
<td class="label">Marker</td>
<td>Type</td>
</tr>
<tr>
<td class="label">CD16/32 (FcγRIII/II)</td>
<td>Fc gamma receptors</td>
</tr>
<tr>
<td class="label">CD86</td>
<td>Co-stimulatory molecule</td>
</tr>
<tr>
<td class="label">iNOS</td>
<td>Enzyme</td>
</tr>
<tr>
<td class="label">MHC-II (HLA-DR)</td>
<td>Surface protein</td>
</tr>
<tr>
<td class="label">CD68</td>
<td>Scavenger receptor</td>
</tr>
<tr>
<td class="label">TNF-α</td>
<td>Cytokine</td>
</tr>
<tr>
<td class="label">IL-1β</td>
<td>Cytokine</td>
</tr>
<tr>
<td class="label">IL-6</td>
<td>Cytokine</td>
</tr>
<tr>
<td class="label">CXCL10</td>
<td>Chemokine</td>
</tr>
<tr>
<td class="label">Therapeutic</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Minocycline</td>
<td>Inhibits microglial activation</td>
</tr>
<tr>
<td class="label">Dexanabinol</td>
<td>NF-κB inhibition</td>
</tr>
<tr>
<td class="label">NR1 (_MEMantine)</td>
<td>NMDA receptor modulation</td>
</tr>
<tr>
<td class="label">TNF-α inhibitors</td>
<td>Block pro-inflammatory cytokine</td>
</tr>
</table>
M1 Polarized Microglia is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
M1 microglia represent the classically activated, pro-inflammatory phenotype that responds to pathogens and damage signals. They are the effector cells of the innate immune system in the central nervous system (CNS), producing high levels of pro-inflammatory cytokines, chemokines, and reactive nitrogen and oxygen species. M1 polarization is induced by stimuli such as lipopolysaccharide (LPS), interferon-gamma (IFN-γ), and tumor necrosis factor-alpha (TNF-α) [1](https://pubmed.ncbi.nlm.nih.gov/26768242/). [@glass2010]
The M1/M2 paradigm, though somewhat simplified, provides a useful framework for understanding microglia phenotypic diversity. M1 microglia are characterized by elevated expression of major histocompatibility complex class II (MHC-II) molecules, cluster of differentiation 86 (CD86), and inducible nitric oxide synthase (iNOS), enabling antigen presentation and production of neurotoxic molecules. [@heneka2015]
<!-- taxonomy-enrichment --> [@liao2012]
<!-- multi-taxonomy-enrichment -->
Multi-Taxonomy Classification
Taxonomy Database Cross-References
Morphology & Electrophysiology
- Morphology: microglial cell (source: Cell Ontology)
- Morphology can be inferred from Cell Ontology classification
PanglaoDB Marker Cross-References
External Database Links
- [Cell Ontology (CL:0000129)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000129)
- [OBO Foundry (CL:0000129)](http://purl.obolibrary.org/obo/CL_0000129)
- [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
- [CellxGene Census](https://cellxgene.cziscience.com/)
- [Human Cell Atlas](https://www.humancellatlas.org/)
- [PanglaoDB](https://panglaodb.se/)
Taxonomy & Classification
PanglaoDB Marker Cross-References
External Database Links
- [Cell Ontology (CL:0000129)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000129)
- [OBO Foundry (CL:0000129)](http://purl.obolibrary.org/obo/CL_0000129)
- [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
- [CellxGene Census](https://cellxgene.cziscience.com/)
- [PanglaoDB](https://panglaodb.se/)
Molecular Markers
M1-polarized microglia express a distinct repertoire of surface markers and secreted molecules:
Signaling Pathways
M1 polarization is driven by several key signaling pathways:
NF-κB Pathway
The nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway is central to M1 polarization. Toll-like receptor (TLR) engagement activates NF-κB, leading to transcription of pro-inflammatory genes including TNF-α, IL-1β, IL-6, and iNOS [2](https://pubmed.ncbi.nlm.nih.gov/22002745/).
JAK/STAT Pathway
IFN-γ binding to its receptor activates JAK1/STAT1 signaling, promoting transcription of M1-associated genes. STAT1 directly upregulates iNOS and MHC-II expression.
MAPK Pathways
p38 MAPK and JNK pathways contribute to M1 polarization by regulating cytokine production and cellular stress responses.
Functions
M1 microglia perform several critical functions:
Pro-inflammatory Responses
M1 microglia secrete pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-12, IL-18) that coordinate the inflammatory response to pathogens and injury.
Pathogen Clearance
Through phagocytosis and production of antimicrobial molecules, M1 microglia eliminate pathogens and cellular debris.
Antigen Presentation
Express MHC-II molecules allow M1 microglia to present antigens to CD4+ T-cells, bridging innate and adaptive immunity.
Cytotoxicity
Production of nitric oxide (via iNOS), reactive oxygen species (ROS), and reactive nitrogen species (RNS) can be cytotoxic to pathogens but also damage nearby neurons and oligodendrocytes.
Induction of Oxidative Stress
NADPH oxidase (NOX2) and iNOS produce superoxide anion and nitric oxide, respectively, which can combine to form peroxynitrite—a highly damaging reactive nitrogen species.
Role in Neurodegenerative Diseases
Alzheimer's Disease (AD)
M1 microglia are prominently involved in Alzheimer's disease pathogenesis. Amyloid-beta (Aβ) plaques and tau pathology activate microglia via TLRs and the NLRP3 inflammasome, driving M1 polarization [3](https://pubmed.ncbi.nlm.nih.gov/28632464/). The resulting chronic neuroinflammation contributes to:
- Synaptic loss and cognitive decline
- Neuronal death in hippocampus and cortical regions
- Progression from mild cognitive impairment (MCI) to AD
- Failure of Aβ clearance mechanisms
Parkinson's Disease (PD)
In Parkinson's disease, M1 microglia are activated by α-synuclein aggregates, neuromelanin, and damage-associated molecular patterns (DAMPs). This contributes to:
- Dopaminergic neuron loss in substantia nigra pars compacta
- Neuroinflammation in basal ganglia circuits
- Motor symptom progression
- Propagation of α-synuclein pathology
Amyotrophic Lateral Sclerosis (ALS)
M1 microglia in ALS produce neurotoxic cytokines and oxidative stress that accelerate motor neuron degeneration. Studies show M1 microglial markers correlate with disease progression [4](https://pubmed.ncbi.nlm.nih.gov/25533934/).
Multiple Sclerosis (MS)
M1 microglia contribute to demyelination and lesion formation in MS. They attack myelin sheaths and produce factors that inhibit oligodendrocyte precursor cell (OPC) differentiation and remyelination.
Therapeutic Targeting
Anti-inflammatory Strategies
Repolarization to M2 Phenotype
Promoting the M2 (neuroprotective) phenotype is a promising strategy:
- IL-4/IL-13: Drive M2 polarization via STAT6
- IL-10: Anti-inflammatory cytokine that suppresses M1
- TGF-β: Promotes M2 and tissue repair
- Acetylcholine: Cholinergic anti-inflammatory pathway
NOX2 Inhibitors
Targeting NADPH oxidase to reduce oxidative stress:
- Apocynin: NOX2 assembly inhibitor
- GKT137831: NOX1/NOX4 inhibitor in clinical trials
See Also
- [Microglia](/cell-types/microglia)
- [M2 Polarized Microglia
- [Disease-Associated Microglia (DAM)m2-polarized-microglia](/content/diseases)
- [Neuroinflammation](/mechanisms/neuroinflammation-pathway)
- [TNF-α in Neurodegeneration
](/diseases/tnf-α-in-neurodegeneration)## Background
The study of M1 Polarized Microglia has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
- [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
- [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
Pathway Diagram
Mermaid diagram (expand to render)